Nanox signs Arkansas distribution deal for Nanox.ARC
Digital X-Ray Imaging will market, install, and support the FDA-cleared multisource digital tomosynthesis system across Arkansas.

Nano-X Imaging has signed a distribution agreement with Digital X-Ray Imaging to expand Nanox.ARC adoption in Arkansas. The agreement was signed through Nanox Impact, the company’s U.S.-based subsidiary.
Under the agreement, DXI will market, install, and support the multisource digital tomosynthesis system across its regional network. Nanox said the network includes major health systems in Arkansas and leading hospital networks in the Little Rock area.
DXI serves hospitals, orthopedic practices, and outpatient clinics across Arkansas. Nanox said the company has more than 3 decades of experience and maintains a statewide team of factory-trained, certified service engineers.
Nanox described Nanox.ARC as an FDA-cleared system that makes 3D imaging possible in more clinical settings at lower cost and reduced radiation dose compared with traditional CT.
This marks Nanox’s 4th U.S. distribution agreement for the system in 2026. Previous agreements involved Integrity Medical Service, Elite Surgical Technologies, and Imperial Imaging Technology.
Digital X-Ray Imaging is a privately held diagnostic imaging provider serving hospitals, clinics, and specialty practices across Arkansas.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section

QT Imaging prices $10M public offering
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.

EDAP, Telix explore PSMA PET and HIFU collaboration
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.

UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.